The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-chloro-10-dodecylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione ID: ALA471341
PubChem CID: 13161691
Max Phase: Preclinical
Molecular Formula: C23H30ClN3O2
Molecular Weight: 415.97
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCCn1c2nc(=O)[nH]c(=O)c-2cc2ccc(Cl)cc21
Standard InChI: InChI=1S/C23H30ClN3O2/c1-2-3-4-5-6-7-8-9-10-11-14-27-20-16-18(24)13-12-17(20)15-19-21(27)25-23(29)26-22(19)28/h12-13,15-16H,2-11,14H2,1H3,(H,26,28,29)
Standard InChI Key: OYYFRRCJRZALJM-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
6.5206 0.5306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2370 0.9440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2341 1.7745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5188 2.1836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8057 0.9435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8099 1.7709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0994 2.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0911 0.5311 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3760 0.9507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3767 1.7815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6615 2.1951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9411 1.7826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9404 0.9518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6602 0.5336 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2252 0.5406 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6633 3.0201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0881 -0.2939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8010 -0.7090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5170 -0.2991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2300 -0.7142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9459 -0.3043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6589 -0.7194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3749 -0.3095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0878 -0.7246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8038 -0.3147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5168 -0.7297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2327 -0.3198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9457 -0.7349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9521 0.5326 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
13 14 1 0
13 15 2 0
5 8 1 0
11 16 2 0
6 7 1 0
8 17 1 0
7 10 2 0
17 18 1 0
9 8 1 0
18 19 1 0
9 10 1 0
19 20 1 0
3 4 2 0
20 21 1 0
4 6 1 0
21 22 1 0
5 6 2 0
22 23 1 0
1 2 2 0
23 24 1 0
5 1 1 0
24 25 1 0
2 3 1 0
25 26 1 0
9 14 2 0
26 27 1 0
10 11 1 0
27 28 1 0
11 12 1 0
2 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 415.97Molecular Weight (Monoisotopic): 415.2027AlogP: 5.76#Rotatable Bonds: 11Polar Surface Area: 67.75Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 6.45CX Basic pKa: ┄CX LogP: 6.12CX LogD: 5.16Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.32Np Likeness Score: -0.76
References 1. Ali HI, Tomita K, Akaho E, Kunishima M, Kawashima Y, Yamagishi T, Ikeya H, Nagamatsu T.. (2008) Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase., 43 (7): [PMID:18055068 ] [10.1016/j.ejmech.2007.10.011 ]